“Finding your dose” is the part of microdosing that the schedules leave open: how much to take. The target practitioners describe is sub-perceptual — low enough that nothing obviously psychedelic happens and an ordinary day is unaffected. That target is defined by its effect on the individual, not by a fixed number, which is why surveys find people using a wide range of amounts rather than one standard dose. The conventional approach is titration: start low, observe, adjust one thing at a time. Two facts complicate the whole exercise. Dosing by mushroom weight is an imperfect proxy — psilocybin content varies between species, batches, and even parts of one mushroom, and people metabolize it differently — so a precisely weighed amount is a precise figure for the wrong quantity. And the response being titrated against is self-rated and expectation-laden, so titration tunes a subjective signal rather than a verified effect. This page is descriptive and cautious; it is not a dose recommendation.
What “sub-perceptual” means
A microdose is defined, before anything else, by what it is not: it is not a dose you feel. The aim is to stay below the threshold of a noticeable psychedelic experience — no clear perceptual changes, no impairment, nothing that interrupts ordinary functioning. People describe this as a “sub-perceptual” or “sub-threshold” dose, and it is the feature that separates microdosing from a low recreational dose. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 Fadiman’s own framing used the same idea of a dose deliberately kept below what a person would feel. [2] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561
The consequence of defining the target by its effect is that the target is personal. The threshold at which effects become noticeable differs from one person to the next, so “sub-perceptual” cannot be reduced to a universal quantity. The dose that is below the line for one person may be at or above it for another. This is the first reason there is no single right number, and it is also why the rest of the work is about finding a dose rather than being told one.
Why there is no standard amount
Survey data make the diversity concrete: studies of real-world microdosers find a wide spread of doses in actual use, not convergence on a standard figure. [3] Observational Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers doi:10.1038/s41598-021-01811-4 Some of that spread is the personal-threshold point above. But a large part of it comes from the material itself.
Psilocybin mushrooms are not a standardized product. The amount of psilocybin in a given weight of dried mushroom varies between species, between cultivation batches, and even between parts of a single mushroom. So two doses that weigh exactly the same can carry meaningfully different amounts of the active compound. [4] Peer-reviewed Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance doi:10.1080/03602532.2016.1278228 This is why a microgram-precise scale can be slightly misleading: it controls the weight of mushroom with great precision while leaving the amount of psilocybin — the thing that matters — uncontrolled.
Why weight is a poor proxy for dose
Dose, exposure, and effect are three different questions. The word “dose” quietly runs together three quantities that are related but not identical: the amount consumed (grams of mushroom), the amount of active compound that reaches the brain (exposure), and the biological or psychological response (effect). Pharmacokinetics governs the step from consumed to exposure; pharmacodynamics governs the step from exposure to response. Weighing a dose controls only the first quantity — and the two conversions that follow are where most of the person-to-person variation lives.
The problem runs one layer deeper than batch variation. Even if the psilocybin content of a dose were known exactly, weight would still be an imperfect proxy for what acts in the brain, for reasons covered in detail in the pharmacokinetics article.
Psilocybin is a prodrug: the body converts it into psilocin, the compound actually responsible for central effects, and then clears psilocin relatively quickly. [4] Peer-reviewed Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance doi:10.1080/03602532.2016.1278228 How efficiently that conversion happens, how much reaches the brain, and how fast it is cleared all vary between individuals. [4] Peer-reviewed Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance doi:10.1080/03602532.2016.1278228 The chain from “grams of mushroom” to “active compound at the receptor” therefore has several lossy, person-specific steps in it. The practical upshot is humility about precision: weighing to two decimal places produces a confident number for a quantity that is several conversions removed from the dose that does anything. [5] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Titration, in practice and in principle
Given all that, the conventional approach is titration — the general clinical principle of approaching a target by starting low and adjusting in small steps while watching the response, rather than guessing the right amount at once. In microdosing practice this translates to beginning at a small amount, holding a schedule long enough to observe more than a couple of dose days, and changing only one variable at a time so that any change can be attributed.
As self-experimentation, that is reasonable method. But it collides with the field’s central limitation, and the collision is worth stating plainly: the “response” being titrated against is a self-rated feeling on a day the person knows is a dose day. The strongest controlled work shows that such self-rated benefits appear under placebo as well as active dose, which means titration is calibrating against a subjective signal that expectation substantially produces. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 Titrating carefully makes the process orderly; it does not make the signal a verified pharmacological effect. A person can dial in a dose that reliably makes them feel a certain way and still be reading mostly expectation.
More is not better
A natural instinct when a low dose seems to do little is to raise it. Two things make that the wrong move. First, push the dose far enough and it crosses the perceptual threshold — at which point it is no longer a microdose at all, but a low recreational dose with different effects, different risks, and a different evidence picture. Second, the idea that “more works better” borrows from full-dose pharmacology, where the strength of the experience does scale with how much receptor is engaged. [6] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 That relationship is established at perceptual doses; it says nothing about benefit at sub-perceptual levels, where the controlled evidence has not established an effect beyond expectation to begin with. [5] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Within the microdose range, more is not better — it is simply closer to a different thing.
- Sub-perceptual target
- A microdose aims to stay below the threshold of a noticeable experience; the target is defined by its effect on the individual, not by a fixed quantity. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
- No standard dose
- Surveys find a wide range of doses in real use, driven by personal thresholds and by variability in mushroom potency. [3] Observational Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers doi:10.1038/s41598-021-01811-4
- Weight is a poor proxy
- Psilocybin content varies by species, batch, and even within a mushroom, and metabolism differs between people — so weight controls the mushroom, not the active dose. [4] Peer-reviewed Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance doi:10.1080/03602532.2016.1278228
- Titration tunes a subjective signal
- Start-low-and-adjust is sound method, but the response being observed is self-rated and expectation-laden, so titration calibrates a feeling, not a verified effect. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
- More is not better
- Raising the dose past the perceptual threshold makes it a different, non-micro intervention; dose-response from full doses does not license escalation within the microdose range. [6] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
Frequently asked questions
What does 'sub-perceptual' actually mean?
Sub-perceptual means a dose low enough that you do not feel obviously intoxicated — no clear visual changes, no impairment, nothing that would stop you going about an ordinary day. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 It is the defining feature of a microdose: the aim is a dose below the threshold of a noticeable psychedelic experience. Because that threshold differs from person to person, “sub-perceptual” is defined by the effect on the individual rather than by a fixed quantity. [2] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561
Is there a standard microdose amount?
There is no standard amount, and surveys of real-world practice find people use a wide range of doses rather than converging on a single figure. [3] Observational Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers doi:10.1038/s41598-021-01811-4 Reports also vary because mushrooms differ in potency and because individuals metabolize psilocybin differently. [4] Peer-reviewed Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance doi:10.1080/03602532.2016.1278228 This page does not give a recommended dose; it describes that doses reported in practice are variable and that the target is defined by staying below the perceptual threshold for that person, not by a universal number.
Why is dosing by mushroom weight unreliable?
Because weight is only a rough stand-in for the amount of active compound that reaches the brain. Psilocybin content varies between species, between batches, and even within a single mushroom, so two equal weights can carry different amounts of psilocybin. [4] Peer-reviewed Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance doi:10.1080/03602532.2016.1278228 On top of that, the body converts psilocybin to psilocin and clears it at rates that differ between people. Weighing to a fine precision gives a precise figure for the wrong quantity: it controls the mushroom, not the dose that acts.
How do people titrate to find their dose?
Titration means starting low and adjusting gradually while observing the response — the general principle of approaching a target dose in small steps rather than guessing it. In microdosing practice this looks like beginning at a small amount, holding a schedule long enough to observe, and adjusting only one variable at a time. The logic is sound self-experimentation, but it runs straight into the field’s central problem: the response being observed is self-rated and shaped by expectation, so titration calibrates a subjective signal, not a verified effect. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
Does a higher microdose work better?
Not in any way the evidence supports, and pushing the dose up defeats the point: cross the perceptual threshold and it is no longer a microdose but a low recreational dose with different effects and risks. Receptor pharmacology shows that effect scales with how much receptor is engaged at perceptual doses, [6] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 but that says nothing about benefit at sub-perceptual levels, where the controlled evidence does not establish an effect beyond expectation in the first place. [5] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 More is not better here; it is simply different.
Are microdosing protocols scientifically proven?
No. The named protocols are schedules that recur in research literature, surveys, and community reports; they give structure for studying and self-tracking the practice, but no controlled trial has shown any schedule to be clinically effective or superior to another. [5] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Current evidence has not established that microdosing produces effects beyond expectation in the first place. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 A protocol is best understood as a documented convention, not a validated treatment regimen.